These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8204 related articles for article (PubMed ID: 1359903)

  • 1. Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.
    Lotze MT; Zeh HJ; Elder EM; Cai Q; Pippin BA; Rosenstein MM; Whiteside TL; Herberman R
    J Immunother (1991); 1992 Oct; 12(3):212-7. PubMed ID: 1359903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4.
    Lindgren CG; Thompson JA; Higuchi CM; Fefer A
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):322-8. PubMed ID: 8280715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinoma.
    Peyret C; Bochner BH; Lee TY; Koo AS; deKernion JB; Belldegrun A
    J Surg Res; 1992 Dec; 53(6):602-9. PubMed ID: 1494294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma.
    Kawakami Y; Rosenberg SA; Lotze MT
    J Exp Med; 1988 Dec; 168(6):2183-91. PubMed ID: 3264324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adoptive immunotherapy and metastasized cancer of the kidney. Regulator effects of interleukin-4 on tumor infiltrating lymphocytes (TIL)].
    Peyret C; Bochner B; Lee TY; Tso CL; Dekernion JB; Belldegrun A
    Chirurgie; 1991; 117(9):700-9. PubMed ID: 1843670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer.
    Zeh HJ; Hurd S; Storkus WJ; Lotze MT
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):155-61. PubMed ID: 7904180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-7 mediates the generation and expansion of murine allosensitized and antitumor CTL.
    Jicha DL; Schwarz S; Mulé JJ; Rosenberg SA
    Cell Immunol; 1992 Apr; 141(1):71-83. PubMed ID: 1555257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.
    Aebersold P; Hyatt C; Johnson S; Hines K; Korcak L; Sanders M; Lotze M; Topalian S; Yang J; Rosenberg SA
    J Natl Cancer Inst; 1991 Jul; 83(13):932-7. PubMed ID: 2067036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY
    Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.
    Yang SC; Fry KD; Grimm EA; Roth JA
    J Immunother (1991); 1991 Oct; 10(5):326-35. PubMed ID: 1790140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4.
    Kawakami Y; Haas GP; Lotze MT
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):336-47. PubMed ID: 8280717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR; Sassenfeld HM; Widmer MB
    J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
    Sica D; Rayman P; Stanley J; Edinger M; Tubbs RR; Klein E; Bukowski R; Finke JH
    Int J Cancer; 1993 Apr; 53(6):941-7. PubMed ID: 8473051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for gene therapy and lymphokine therapy for metastatic melanoma.
    Sivanandham M; Scoggin SD; Sperry RG; Wallack MK
    Ann Plast Surg; 1992 Jan; 28(1):114-8. PubMed ID: 1642399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
    Chang AE; Aruga A; Cameron MJ; Sondak VK; Normolle DP; Fox BA; Shu S
    J Clin Oncol; 1997 Feb; 15(2):796-807. PubMed ID: 9053507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.
    Steger GG; Kaboo R; deKernion JB; Figlin R; Belldegrun A
    Br J Cancer; 1995 Jul; 72(1):101-7. PubMed ID: 7599037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
    Donia M; Junker N; Ellebaek E; Andersen MH; Straten PT; Svane IM
    Scand J Immunol; 2012 Feb; 75(2):157-67. PubMed ID: 21955245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3'-truncated interleukin-2 gene.
    Yamaue H; Kashmiri SV; De Filippi R; Nieroda C; Yannelli JR; Tsang KY; Schlom J
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):262-74. PubMed ID: 7881635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
    Böhm M; Möller P; Kalbfleisch U; Worm M; Czarnetzki BM; Schadendorf D
    Br J Cancer; 1994 Jul; 70(1):54-9. PubMed ID: 8018541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
    Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 411.